<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sat, 05 Dec 2009 19:37:14 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>The Deep, Inner Meaning Of Bank of America's (BAC) TARP Repayment</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</guid>
      <description><![CDATA[As expected, Bank of America (BAC) will repurchase its $45 billion TARP preferreds, funded in part by an additional $18.8 billion in &quot;common stock equivalents&quot;, $4.0 billion in asset sales, and $1.7 billion in restricted stock issued to employees in lieu of cash bonuses.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3688027>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 14:19:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WFC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</link>
    </item>
    <item>
      <title>Forget Yesterday, It's All About Jobs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</guid>
      <description><![CDATA[Good morning. Stocks tanked in the last half-hour on Thursday and while the major news outlets attributed the decline to either profit taking or some trepidation in front of this morning's big Jobs report, we'd like to offer a little more substantial reason for the 85 point dive on an otherwise subdued day of trading.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3687896>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 13:21:30 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVLT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSLR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPRO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRVL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NFLX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">V</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRSN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</link>
    </item>
    <item>
      <title>Fed Balance Sheet Declines By $15 Billion After Improbable Reduction In MBS, Excess Reserves, Monetary Base Hit Record</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</guid>
      <description><![CDATA[The Federal Reserve's balance sheet declined by $15 billion to $2,183 billion from the prior week, after the Fed presumably offloaded $2.7 billion in MBS: this is the first time since QE started that MBS holdings have declined. If anyone can tell us just who the idiots are who bought MBS from the Fed (and at what price), and who the even greater idiots are who are supposed to believe this, please send us an email.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3686922>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 04:14:41 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</link>
    </item>
    <item>
      <title>China Will Continue To Drive The Global Economic Recovery In 2010</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</guid>
      <description><![CDATA[China isn’t just leading the global economic recovery – it’s lapping the field.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683989>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 14:38:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GROW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</link>
    </item>
    <item>
      <title>Interesting Stat: How Much Private Sector GDP Is From Construction And Real Estate?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</guid>
      <description><![CDATA[Back in June, we discussed commercial real estate at length following attendance at a large real estate conference in NYC. Our tone was cautious and one question we wondered about was the percentage of GDP that real estate represents. We actually came across the answer back in August and meant to share then, but didn't get to it. Since the question/topic remains highly relevant to considering the potential negative economic drag from depressed real estate activity, we're sharing now -- the following table is from an 8/28/09 NYTs article, &quot;Construction That Fueled Growth in the Sun Belt Slows&quot;:<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683785>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 13:15:56 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</link>
    </item>
    <item>
      <title>Credit Market Overview:  Dec 3, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</guid>
      <description><![CDATA[The credit crunch crisis of confidence which we appear to be crawling out of even though the debt and equity markets catapulted themselves higher earlier this year could be similarly argued to be a crisis that started in the credit markets which crunched confidence around the world as it could a collapse in confidence in the value of the securities investors held which corrupted the credit markets causing them to cease funding.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683773>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 12:59:02 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</link>
    </item>
    <item>
      <title>Grab Some Northern Exposure With EWC</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</guid>
      <description><![CDATA[Emerging markets are captivating investors again, but tidy profits aren’t always far away. Placing your bets on well-established global markets can also prove rewarding. That's why we're looking at Canada.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682040>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:39:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RIMM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</link>
    </item>
    <item>
      <title>Unemployment Struggling To Turn A Corner As Job Losses Mount In November</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</guid>
      <description><![CDATA[U.S. job losses in the private sector slowed in November but still exceeded economists’ projections, a report by payroll-processing firm Automatic Data Processing (Nasdaq: ADP) indicated yesterday (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681965>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:20:20 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</link>
    </item>
    <item>
      <title>Why Barrick Closed Their Gold Hedge</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</guid>
      <description><![CDATA[It sure looks like gold is going to close above $1,200 an ounce today in New York. And large open market purchases from central banks in China, India and Russia are only helping the price surge more. (Just one year ago, some of these same central banks were actually selling gold in an attempt to fill an annual 10,000-ton supply gap.)<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681409>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 19:15:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PAAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SSRI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</link>
    </item>
    <item>
      <title>How To Profit From The 'Next' Dubai</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</guid>
      <description><![CDATA[The Dubai World default is a matter of only $60 billion – mere peanuts when compared to other elements of the global financial crisis. It’s thus of concern only to those silly enough to invest in real estate there (and the European banks foolish enough to finance it.) For the rest of us, it is a useful reminder that sudden collapses don’t really come out of nowhere – they can be foreseen, and smart investors can plan for them.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3679796>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 13:51:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</link>
    </item>
    <item>
      <title>Inspire reports $8.5 million 3Q loss</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3614393</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 6--DURHAM -- Inspire Pharmaceuticals Inc. on Thursday reported a loss of $8.5 million for the third quarter, mostly owing to an increase in expenses even as revenues for the company's lead products rose. &lt;/li&gt;&lt;li&gt;Operating expenses for the third quarter totaled $33.1 million, up from $29 million a year ago, primarily because of higher research and development expenses, including a $3.3 million milestone payment to Yamasa Corp. for a technology agreement to enable a two-supplier strategy for denufosol, the company's candidate for treating cystic fibrosis. &lt;/li&gt;&lt;li&gt;Revenue from Azasite, the company's candidate for treating pinkeye, was $9.0 million, nearly double the $4.7 million from the third quarter of 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3614393>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 17:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3614393</link>
    </item>
    <item>
      <title>Allergan Wins Patent Infringement Lawsuit Against Exela and Apotex</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3579038</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Allergan, a multi-specialty healthcare company, has reported that the US District Court of Delaware ruled in favor of the company in its patent infringement suit against Exela PharmSci Inc, Exela PharmSci, Apotex Inc and Apotex for seeking to market purported generic versions of Allergan's drugs Alphagan P 0.1% and 0.15%.&lt;/li&gt;&lt;li&gt;Specifically, after a trial in March of 2009, the court ruled that all five patents asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of Alphagan P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of Alphagan P 0.15% infringes US patent, which was the only patent asserted against it. &lt;/li&gt;&lt;li&gt;Pursuant to the Hatch-Waxman Act, the FDA is required to delay approval of defendants' proposed generic products until the last to expire of the infringed patents, which is 2022.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3579038>[More...]</a>]]></description>
      <pubDate>Mon, 26 Oct 2009 14:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3579038</link>
    </item>
    <item>
      <title>Allergan Q2 Net Earnings Up</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3388509</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Allergan, a multi-specialty healthcare company, has reported net earnings attributable to the company of $176.1 million, or $0.58 per diluted share, for the second quarter ended June 30, 2009, compared to $143.4 million, or $0.47 per diluted share, in the second quarter of 2008.&lt;/li&gt;&lt;li&gt;For the second quarter of 2009, total revenues were $1.13 billion, compared to $1.17 billion in the second quarter of 2008.&lt;/li&gt;&lt;li&gt;For the first six months ended June 30, 2009, total revenues were $2.14 billion, compared to $2.25 billion in the same period of 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3388509>[More...]</a>]]></description>
      <pubDate>Mon, 03 Aug 2009 14:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3388509</link>
    </item>
    <item>
      <title>FDA orders botulinum toxin warnings</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3281884</guid>
      <description><![CDATA[FDA orders botulinum toxin warnings<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3281884>[More...]</a>]]></description>
      <pubDate>Wed, 10 Jun 2009 16:02:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3281884</link>
    </item>
    <item>
      <title>Correction: Allergan story</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3140687</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WASHINGTON - In a March 20 story about Allergan Inc.'s executive compensation, The Associated Press reported erroneously that the company's 2008 fiscal year ended in October. &lt;/li&gt;&lt;li&gt;A corrected version of the story appears below.&lt;/li&gt;&lt;li&gt;WASHINGTON (AP) - The chief executive of Allergan Inc., maker of Botox anti-wrinkle injections and breast implants, received $13.6 million in total compensation last year, a more than 20 percent increase, according to an analysis by the Associated Press.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3140687>[More...]</a>]]></description>
      <pubDate>Mon, 23 Mar 2009 20:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3140687</link>
    </item>
    <item>
      <title>Nightly Business Report - Mar 21 2009  5:53AM</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3137084</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;SUSIE GHARIB, NIGHTLY BUSINESS REPORT ANCHOR:  House Democrats go all  out to get the AIG bonus money back.  &lt;/li&gt;&lt;li&gt;DARREN GERSH, NIGHTLY BUSINESS REPORT ANCHOR:  And the Fed`s bold move  to buy up billions in mortgage-backed securities had phones ringing off the  hook at mortgage lenders today. &lt;/li&gt;&lt;li&gt;This is  NIGHTLY BUSINESS REPORT for Thursday, March 19.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3137084>[More...]</a>]]></description>
      <pubDate>Thu, 19 Mar 2009 09:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">C</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CCL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">Q</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">QCOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3137084</link>
    </item>
    <item>
      <title>Midday Dividend Scan: Commercial Metals - Twelve Cents; CTS - $0.03; Heinz - 41.5 cents; Medicis - $0.04; Staples - $0.0825</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3108641</guid>
      <description><![CDATA[Midday Dividend Scan: Commercial Metals - Twelve Cents; CTS - $0.03; Heinz - 41.5 cents; Medicis - $0.04; Staples - $0.0825<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3108641>[More...]</a>]]></description>
      <pubDate>Wed, 11 Mar 2009 18:21:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CTS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HNZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPLS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3108641</link>
    </item>
    <item>
      <title>Jobless Claims Tally Highest Since 1982</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3022124</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WASHINGTON -- New jobless claims jumped far more than expected last week in an already dismal labor market, and there's no relief in sight for workers as mass layoffs persist.  &lt;/li&gt;&lt;li&gt;The Labor Department reported Thursday that the number of newly jobless workers seeking benefits rose last week to a seasonally adjusted 626,000, from the previous week's upwardly revised figure of 591,000. &lt;/li&gt;&lt;li&gt;The numbers reflect the large spate of layoffs announced last month by companies from all sectors of the economy, including Caterpillar Inc., Pfizer Inc. and Microsoft Corp.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3022124>[More...]</a>]]></description>
      <pubDate>Fri, 06 Feb 2009 15:54:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LIZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">M</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PLCE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PNC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TWX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3022124</link>
    </item>
    <item>
      <title>Jobless Rate Still Up; Sales Still Weak</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3017325</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WASHINGTON -- More people sought unemployment benefits than expected last week and laid-off workers found it harder to land new jobs as the economy struggled to show signs of life.&lt;/li&gt;&lt;li&gt;Sour economic indicators Thursday also plagued the retail industry: Weak factory orders were reported for December and sales declines last month for many major stores raised concerns about the industry's health.&lt;/li&gt;&lt;li&gt;Productivity rose sharply in the final months of the year, the government said -- but only because layoffs cut the number of hours worked more than output fell.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3017325>[More...]</a>]]></description>
      <pubDate>Fri, 06 Feb 2009 13:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LIZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LTD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">M</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PNC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TWX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3017325</link>
    </item>
    <item>
      <title>Botox Sales Sag, Surprising Maker Allergan Thought Recession Wouldn't Affect Wrinkle Shots</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3016882</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Wrinkled faces may be the latest example of recession chic. &lt;/li&gt;&lt;li&gt;As consumers cut back in the third quarter of last year on expensive aesthetic procedures like breast implant operations, pharmaceutical executives and doctors had predicted that one segment of the cosmetic medicine market would prove more resistant to the weak economy: antiwrinkle shots like Botox.&lt;/li&gt;&lt;li&gt;But the earnings report Wednesday from Allergan, the maker of Botox and a leader in cosmetic medical products, indicates  that revenue from the less expensive injection treatments is also faltering.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3016882>[More...]</a>]]></description>
      <pubDate>Fri, 06 Feb 2009 10:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3016882</link>
    </item>
    <item>
      <title>Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update; ZEVALIN&amp;#174; Sales up 80% over Third Quarter 2008</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3628832</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage   biotechnology company with a primary focus in oncology, today reported   financial results for the third quarter ended September 30, 2009.&lt;/li&gt;&lt;li&gt;Third Quarter Results1   Ended September 30, 2009&lt;/li&gt;&lt;li&gt;Selling, general and   administrative expenses were $7.0 million, a $3.9 million increase,   compared to the $3.1 million in the same period in 2008, attributable to   the direct cost of commercialization activities of ZEVALIN and FUSILEV   and related payroll costs.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3628832>[More...]</a>]]></description>
      <pubDate>Thu, 12 Nov 2009 11:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3628832</link>
    </item>
    <item>
      <title>Phase Forward Reports Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data   management solutions for clinical trials and drug safety, today   announced its financial results for the third quarter of 2009.&lt;/li&gt;&lt;li&gt;Within total   revenues, electronic data capture (EDC) license, application hosting and   other related revenues were $38.5 million, representing 71% of third   quarter total non-GAAP revenues and an increase of 18% from $32.7   million in the prior year period.&lt;/li&gt;&lt;li&gt;Weiler added, &quot;During the third quarter, a pharmaceutical company in the   top 40 in sales selected Phase Forward's InForm EDC solution for a   multi-year, multi-million dollar commitment, while a leading provider of   information technology, consulting, and business process outsourcing   services selected InForm as part of their outsourcing services to a top   10 pharma.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3591497>[More...]</a>]]></description>
      <pubDate>Thu, 29 Oct 2009 20:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFWD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3591497</link>
    </item>
    <item>
      <title>Allergan Announces Victory in Brimonidine Patent Infringement Case</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3577039</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Allergan, Inc. (NYSE:AGN) announced today that the United States   District Court for the District of Delaware ruled in favor of Allergan,   Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela   PharmSci Pvt., Ltd. (&quot;Exela&quot;), Apotex, Inc. and Apotex Corp. (&quot;Apotex&quot;)   (collectively, the &quot;Defendants&quot;) for seeking to market purported generic   versions of Allergan's drugs ALPHAGAN&amp;#174; P (brimonidine   tartrate ophthalmic solution) 0.1% and 0.15%. &lt;/li&gt;&lt;li&gt;6,627,210; 6,641,834; 6,673,337; 6,562,873; and   5,424,078) asserted by Allergan are valid and enforceable, that Apotex's   proposed generic versions of ALPHAGAN&amp;#174; P 0.1% and 0.15%   infringe each of the five patents, and that Exela's proposed generic   version of ALPHAGAN&amp;#174; P 0.15% infringes U.S. Patent No.   &lt;/li&gt;&lt;li&gt;6,641,834, which was the only patent asserted against it.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3577039>[More...]</a>]]></description>
      <pubDate>Sat, 24 Oct 2009 04:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3577039</link>
    </item>
    <item>
      <title>Licensing Executives Society Announces 2009 Deals of Distinction Awards</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3569701</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Intellectual property (IP) development and the licensing of IP is an   essential component of innovation in our knowledge-based economy. &lt;/li&gt;&lt;li&gt;To highlight the best of these deals, the Licensing Executives Society   (USA &amp; Canada), Inc. (LES) today presented its Deals of DistinctionTM   Awards to winners in five industry sectors. &lt;/li&gt;&lt;li&gt;&quot;Now more than ever, our economy needs intellectual property and the   innovation in products and services that IP helps to achieve,&quot; said   Rimma Driscoll, chair of the LES Deals of Distinction Award Committee.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3569701>[More...]</a>]]></description>
      <pubDate>Wed, 21 Oct 2009 19:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UTHR</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3569701</link>
    </item>
    <item>
      <title>RidgewaterEquity.Com Free Fundamental Sector &amp;Amp; Market Research on MRX, RPM, BKE, NMR, BLL and SSL</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3544312</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;RidgewaterEquity.com inspires to bring the best from the internet under one roof, providing you with a one click option to view what the market, researchers and financial pundits worldwide have to say about any particular large cap stocks in any given financial environment. &lt;/li&gt;&lt;li&gt;Once you sign up as a free member you will have free unlimited access to all our reports, research tools and more.&lt;/li&gt;&lt;li&gt;We have recently begun in-depth analysis of the following equities &amp;amp; their respective sectors:&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3544312>[More...]</a>]]></description>
      <pubDate>Mon, 12 Oct 2009 12:05:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BKE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BLL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NMR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RPM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SSL</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3544312</link>
    </item>
    <item>
      <title>SYSPRO Honored for Business Excellence</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3496834</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;SYSPRO, a provider of visionary ERP   for the manufacturing pragmatist, today announced that the company has   received an award from the Orange County Chapter of the British American   Business Council (BABC-OC). &lt;/li&gt;&lt;li&gt;Joey Benadretti, President of SYSPRO USA, accepted the award for SYSPRO,   which was presented by Dame Barbara Hay, British Consul General in Los   Angeles. &lt;/li&gt;&lt;li&gt;Benadretti shared the dais with other honored companies  -- Ceradyne Inc., Allergan Inc., Sage Software  -- and participated in a   panel discussion on specific business issues and the state of the   economy with executives from these organizations, respectively Joel   Moskowitz, Doug Ingram and Richard Forsythe.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3496834>[More...]</a>]]></description>
      <pubDate>Tue, 22 Sep 2009 13:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRDN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3496834</link>
    </item>
    <item>
      <title>Investment Industry Regulatory Organization of Canada - Trade Resumption - ICS Copper Systems Ltd. - ICX</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3474455</guid>
      <description><![CDATA[VANCOUVER, Sept. 11 /CNW/ - Trading resumes in: Issuer Name: ICS Copper Systems Ltd. TSX-V Ticker Symbol: ICX<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3474455>[More...]</a>]]></description>
      <pubDate>Fri, 11 Sep 2009 13:05:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ICX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3474455</link>
    </item>
    <item>
      <title>ICS finds JV partner</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3471113</guid>
      <description><![CDATA[ABBOTSFORD, BC, Sept. 10 /CNW/ - ICS Copper Systems Ltd. (ICX:TSX.V) is pleased to announce that it has signed a Heads of Agreement with two Zambian companies that have a strategic relationship with each other, namely JV Civils Ltd (&quot;JVC&quot;) and Chantete Emeralds Ltd (&quot;Chantete&quot;). The principal operations of these companies encompass bulk earthworks, plant hire, material transportation, crushing and material handling mainly on the Zambian Copperbelt.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3471113>[More...]</a>]]></description>
      <pubDate>Thu, 10 Sep 2009 18:17:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ICX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3471113</link>
    </item>
    <item>
      <title>BenchmarkJournal.Com Free Analyst Review for ACN, CHL, L, AGN, BA and AMX</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3443399</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Benchmark Journal brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear picture of investment opportunities. &lt;/li&gt;&lt;li&gt;Today we began research on Accenture Ltd. (NYSE: ACN), China Mobile Ltd. (NYSE: CHL), Loews Corporation (NYSE: L), Allergan Inc. (NYSE: AGN), The Boeing Company (NYSE: BA) and America Movil S.A.B de C.V. (NYSE: AMX).&lt;/li&gt;&lt;li&gt;To view our research, sign up now and get started with your complimentary subscription.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3443399>[More...]</a>]]></description>
      <pubDate>Fri, 28 Aug 2009 12:06:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CHL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">L</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3443399</link>
    </item>
    <item>
      <title>Morning Watch for Wednesday: Sunwin International Neutraceuticals - August 19, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3424078</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Stock Market Alerts' performance stock list includes: Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), Bristol-Myers Squibb Company (NYSE: BMY), Johnson &amp;amp; Johnson (NYSE: JNJ) and Medicis (NYSE: MRX).&lt;/li&gt;&lt;li&gt;Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) recently reported its financial results for the fiscal year 2009, which included record sales of stevioside that reached $14.5 million for the full fiscal year of 2009, an increase of 12.4% over the $12.9 million recorded in fiscal 2008. &lt;/li&gt;&lt;li&gt;On July 30th, 2009, the company reported it's financial results for the fiscal year ended April 30, 2009.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3424078>[More...]</a>]]></description>
      <pubDate>Wed, 19 Aug 2009 13:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAAH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CNAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SUWN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3424078</link>
    </item>
    <item>
      <title>Form  4          ALLERGAN INC              For: Nov 30  Filed by: INGRAM ROBERT ALEXANDER (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682238</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682238>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 22:30:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682238</link>
    </item>
    <item>
      <title>Form  4          ALLERGAN INC              For: Nov 30  Filed by: Dunsire Deborah (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682235</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682235>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 22:29:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682235</link>
    </item>
    <item>
      <title>Form  4          ALLERGAN INC              For: Nov 30  Filed by: GALLAGHER MICHAEL R (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682231</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682231>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 22:28:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682231</link>
    </item>
    <item>
      <title>Form  4          ALLERGAN INC              For: Nov 30  Filed by: BOYER HERBERT W PH D (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682226</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682226>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 22:26:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682226</link>
    </item>
    <item>
      <title>Form  4          MEDICIS PHARMACEUTICAL    For: Nov 25  Filed by: PIETRANGELO MICHAEL (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3673103</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3673103>[More...]</a>]]></description>
      <pubDate>Mon, 30 Nov 2009 20:33:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3673103</link>
    </item>
    <item>
      <title>Form  4          HERBERT GAVIN S           For: Nov 10 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3624989</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3624989>[More...]</a>]]></description>
      <pubDate>Wed, 11 Nov 2009 00:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3624989</link>
    </item>
    <item>
      <title>Form  4          EDWARDS JEFFREY L         For: Nov 06 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3618593</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3618593>[More...]</a>]]></description>
      <pubDate>Mon, 09 Nov 2009 17:14:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3618593</link>
    </item>
    <item>
      <title>Form  4          Diradoorian Raymond H     For: Nov 05 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3618590</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3618590>[More...]</a>]]></description>
      <pubDate>Mon, 09 Nov 2009 17:11:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3618590</link>
    </item>
    <item>
      <title>Form  4          GALLAGHER MICHAEL R       For: Nov 03 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608075</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608075>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608075</link>
    </item>
    <item>
      <title>Form  4          INGRAM DOUGLAS S          For: Nov 03 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3608023</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3608023>[More...]</a>]]></description>
      <pubDate>Wed, 04 Nov 2009 21:32:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3608023</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=AGN,CYNO,ICX,MRX," rel="self" type="application/rss+xml" />
  </channel>
</rss>